← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #532 OF 1,000 MOST-CITED

Approval and review of procedures

FDA cited this observation 35 times across 35 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs35
BY FISCAL YEAR
FY20261
FY20254
FY20241
FY20235
FY20226
FY20203
FY20197
FY20186
FY20172

How FDA worded it — real examples

Written procedures are not reviewed and approved by the quality control unit.

Skytronics Led, Inc · Burbank, California · Drugs · 2026-01-12

Written procedures are not drafted, reviewed and approved by the appropriate organizational units.

ChiRhoClin, Inc · Burtonsville, Maryland · Drugs · 2025-09-15

Written procedures are not drafted, reviewed and approved by the appropriate organizational units.

Barr Laboratories Inc. · Forest, Virginia · Drugs · 2025-05-09

Written procedures are not drafted, reviewed and approved by the appropriate organizational units.

EMINENT Services Corporation · Frederick, Maryland · Drugs · 2025-04-28

Written procedures are not drafted, reviewed and approved by the appropriate organizational units.

Scapa Tapes North America LLC · Knoxville, Tennessee · Drugs · 2025-01-23

Written procedures are not drafted, reviewed and approved by the appropriate organizational units.

Products By O2, Inc · Fort Lauderdale, Florida · Drugs · 2023-10-23

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharmaceutical quality systemPharma industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →